Reports and presentations

Latest result publication:

Half Year Financial Review January–June 2025

 

 

 

 

Half Year Financial Review January-June 2025

Report

Presentation

Webcast

Webcast transcript

Key figures (Excel)

 

 

Q2/2025 in brief

  • Orders received increased to EUR 1,520 million

  • Net sales amounted to EUR 1,21 billion

  • Order backlog was EUR 4.7 billion

  • Comparable EBITA was EUR 143 million and margin was 11.5%

 

 

President and CEO Thomas Hinnerskov: New 'Lead the Way' strategy launched and strong growth in orders received
 

"In the second quarter, we made a confident move toward our next phase of growth by launching our new strategy, ‘Lead the Way’, and setting ambitious 2030 financial targets. This strategy is designed to accelerate growth, sharpen our cost competitiveness, and build a culture of accountability and high performance. Our new financial targets reflect a clear step change in ambition, and we now have a focused strategy to reach them.

A major milestone was the implementation of our new operating model on July 1. It simplifies our structure, reinforces local accountability, and enables faster decision-making. Going forward, we will operate through two segments – each with a distinct strategic mission and aligned financial reporting. The segments are Biomaterial Solutions and Services; and Process Performance Solutions.

I’ve had the opportunity to meet with customers since the strategy launch, and the feedback has been encouraging. Our purpose to transform industries towards a regenerative tomorrow and our lifecycle approach have resonated well.

Operationally, the second quarter was strong in terms of orders received. Automation segment (Process Performance Solutions) delivered across the board, with growth in orders, net sales, and profitability. Process Technologies and Services segments (Biomaterial Solutions and Services) also achieved strong order growth, including a 10 percent organic increase in Services orders, although profitability in Process Technologies declined due to lower net sales.

While net sales and Comparable EBITA remained at the previous year’s level during H1/25, we are confident that the actions we are taking – including the new operating model – will support our performance and competitiveness going forward. We remain committed to executing our strategy with discipline and creating long-term value for our customers and shareholders."